Yaqiong Zhang,
Yijie Zhao,
Meng Wang,
Jiaqi Wang,
Zhicheng Yang,
Mengmeng Lu
Department of Oral and Maxillofacial Surgery, Shanghai Stomatological Hospital, Fudan University & Shanghai Key Laboratory of Craniomaxillofacial Development and Diseases, Fudan University, Shanghai 200031, China;
For correspondence:- Mengmeng Lu
Email: lumengmeng_kq@fudan.edu.cn
Accepted: 12 December 2022
Published: 31 January 2023
Citation:
Zhang Y, Zhao Y, Wang M, Wang J, Yang Z, Lu M.
Effect of clopidogrel on post-extraction clotting in patients on dual antiplatelet therapy. Trop J Pharm Res 2023; 22(1):189-197
doi:
10.4314/tjpr.v22i1.26
© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To evaluate the association between the platelet inhibition rate of clopidogrel (CLO-PIR) and post-extraction clotting status in DAPT patients.
Methods: Ninety (90) eligible patients scheduled for a single tooth extraction were enrolled in this study. The CLO-PIR and platelet inhibition rate of aspirin (ASA-PIR) were determined by thromboelastography platelet mapping assay. Post-extraction clotting assessments were performed, and a complete intra-alveolar clot formation within 30 min post-operation was defined as normal clotting. For clot formation exceeding 30 min, it was defined as prolonged bleeding.
Results: At a similar level of ASA-PIR, a higher proportion of patients with normal CLO-PIR (≤ 75 %) exhibited normal clotting, compared with those featuring high CLO-PIR (>75 %, p < 0.001). However, in patients with similar CLO-PIRs, the clotting results varied insignificantly, with increase in ASA-PIR. The effect of CLO-PIR was further validated using logistic regression analysis (odds ratio = 1.071, 95 % confidence interval: 1.024 - 1.120, p = 0.003), and receiver operating characteristic curve analysis revealed that a 78.6 % CLO-PIR was the rational cut-off point.
Conclusion: This study preliminarily demonstrates the prominence of high clopidogrel responsiveness in slowing the post-extraction clotting process in DAPT patients.
Keywords: Dual antiplatelet therapy, Clopidogrel responsiveness, Dental extraction, Post-extraction clotting, Thromboelastography platelet mapping assay, Platel